Diane Ashiru-Oredope, John D. Perry

    Research output: Contribution to journalEditorial

    Original languageEnglish
    Pages (from-to)vi1
    JournalJournal of Antimicrobial Chemotherapy
    Publication statusPublished - 1 Jun 2018

    Bibliographical note

    Funding Information:
    In both human and economic terms, antimicrobial resistance presents an increasing global burden and the development of new antimicrobials, as well as the effective stewardship of existing agents, is critically important. DRIVE-AB (Driving re-investment in Research and Development and responsible antibiotic use) is a project composed of public and private partners from 12 countries ( It is funded by the Innovative Medicines Initiative (IMI); a joint undertaking between the European Union and the European Pharmaceutical Industry Association (EFPIA). The DRIVE-AB consortium is tasked with defining responsible use of antibiotics, identifying antibiotic-related public health priorities, calculating the societal value of developing new antibiotics, and developing new economic models to promote the required innovation and sustainable use of new antibiotics.

    Cite this